Abstract
The contraction and relaxation velocities of single myocytes isolated from failing and nonfailing left and right human ventricles have been compared in order to investigate the possible contribution of cellular changes to the diastolic dysfunction seen in vivo. Myocytes from the failing right ventricle (RV) showed slowed relaxation compared to those from nonfailing, and the change was quantitatively similar to that seen in the failing left ventricle (LV). Poor relaxation was observed in RV myocytes from patients with ischemic heart disease, idiopathic dilated cardiomyopathy, and congenital heart disease. Division of patients into groups with high and low pulmonary artery pressure (PAP) showed a significant relation between raised PAP and slow relaxation of RV myocytes. Cells from the high PAP group were also longer, but not wider, than those from the low PAP group. β-adrenoceptor desensitization was evident in RV myocytes from failing heart, but did not diger in magnitude between high and low PAP groups. As we have previously shown for the LV, diastolic dysfunction in the RV may be related to changes in myocyte function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
del Monte F, O’Gara P, Poole-Wilson PA, Yacoub MH, Harding SE. 1995. Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. Cardiovasc Res 30:281–290.
Harding SE, Jones SM, O’Gara P, del Monte F, Vescovo G, Poole-Wilson PA. 1992. Isolated ventricular myocytes from failing and non-failing human heart; the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol 24:549–564.
Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, Harding SE. 1995. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92:2540–2549.
Souffer R, Wohlgelernter D, Vita NA, Amuchestegui M, Sostman HD, Berger H, Zaret B. 1985. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 55:1032–1036.
Litwin SE, Grossman W. 1993. Diastolic dysfunction as a cause of heart failure (review). J Am Coll Cardiol 22:49A–55A.
Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. 1986. Assessment of the B-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74:1290–1302.
Mulieri LA, Hasenfuss G, Leavitt BJ, Allen PD, Alpert NR. 1992. Altered myocardial force-frequency relation in human heart failure. Circulation 85:1743–1750.
Rihal CS, Nishimura RA, Hade LK, Bailey KR, Tajik J. 1994. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Circulation 90:2772–2779.
Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. 1987. Abnormal intracellular calcium handing in myocardium from patients with end stage heart failure. Cardiovasc Res 61:70–76.
Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB. 1986. B1-and B2-adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective B1-receptor down-regulation in heart failure. Circ Res 59:297–309.
Gwathmey JK, Slawsky MT, Hajjar RJ, Briggs GM, Morgan JP. 1990. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest 85:1599–1613.
Schwinger RHG, Bohm M, Muller-Ehmsen J, Uhlman R, Schmidt U, Stablein A, Ubetfuhr P, Kreuzer E, Reichart B, Eissner H-J, Erdmann E. 1993. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart. Circulation 88:2267–2276.
Gerdes AM, Kellerman SE, Moore JA, Muffly KE, Clark LC, Reaves PY, Malec KB, McKeown PP, Schocken DD. 1992. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation 86:426–430.
Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P. 1994. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89:151–163.
Yu CM, Sanderson JE, Chan S, Yeung L, Hung YT, Woo KS. 1996. Right ventricular diastolic dysfunction in heart failure. Circulation 93:1509–1514.
Harding SE, Vescovo G, Kirby M, Jones SM, Gurden J, Poole-Wilson PA. 1988. Contractile responses of isolated rat and rabbit myocytes to isoproterenol and calcium. J Mol Cell Cardiol 20:635–647.
Gerdes AM, Capasso JM. 1995. Structural remodelling and mechanical dysfunction of cardiac myocytes in hem failure. J Mol Cell Cardiol 27:849–856.
Poole-Wilson PA. 1995. The dimensions of human cardiac myocytes; confusion caused by methodology and pathology (comment). J Mol Cell Cardiol 27:863–865.
Danielsen W, van der Leyen H, Meyer W, Neumann J, Schmitz W, Scholz H, Starbatty J, Stein B, Doring V, Kalmar P. 1989. Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations. J Cardiovasc Pharmacol 14:171–173.
von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Schmitz W, Scholz H, Starbatty J, Stein B, Wenzlaff, Doring V, Kalmar P, Haverich A. 1991. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations. Naunyn-Schmiedebergs Arch Phamacol 344:90–100.
Bohm M, Reiger B, Schwinger RHG, Erdmann E. 1994. cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res 28:1713–1719.
Wynne DG, del Monte F, Harding SE. 1996. Cyclic AMP levels in ventricular myocytes from noradrenaline-treated guinea-pigs. Eur J Pharmacol 310:235–242.
Harding SE, Brown LA, del Monte F, Davies CH, O’Gara P, Vescovo G, Wynne DG, Poole-Wilson PA. 1996. Acceleration of contraction by β-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts. Basic Res Cardiol 91(Suppl 2):53–56.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Kluwer Academic Publishers
About this chapter
Cite this chapter
Harding, S.E., del Monte, F., Poole-Wilson, P.A. (1998). Function of Cardiac Myocytes in Ischemicheart Disease: Comparative Changes in Right and Left Ventricular Cells. In: Mochizuki, S., Takeda, N., Nagano, M., Dhalla, N.S. (eds) The Ischemic Heart. Progress in Experimental Cardiology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-39844-0_1
Download citation
DOI: https://doi.org/10.1007/978-0-585-39844-0_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-8105-1
Online ISBN: 978-0-585-39844-0
eBook Packages: Springer Book Archive